Capital Advisors Ltd’s Ionis Pharmaceuticals IONS Stock Holding History

Capital Advisors Ltd’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23K	Hold	295	–	–	﹤0.01%	659
2026 Q1	$22K	Hold	295	–	–	﹤0.01%	645
2025 Q4	$23K	Hold	295	–	–	﹤0.01%	623
2025 Q3	$19K	Hold	295	–	–	﹤0.01%	660
2025 Q2	$12K	Buy	+295	New	+$9.65K	﹤0.01%	744
2025 Q1	–	Sell	-179	Closed	-$6K	–	1455
2024 Q4	$6K	Buy	+179	New	+$6.69K	﹤0.01%	909
2024 Q2	–	Sell	-7	Closed	–	–	1510
2024 Q1	$0	Buy	+7	New	+$334	﹤0.01%	1453
2023 Q1	–	Sell	-63	Closed	-$2K	–	1368
2022 Q4	$2K	Buy	63 +59	+1,475%	+$2.48K	﹤0.01%	863
2022 Q3	$0	Buy	+4	New	+$169	﹤0.01%	1353

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Advisors Ltd's IONS Position: Q2 2026 in Review

Capital Advisors Ltd held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 295 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Capital Advisors Ltd first reported a position in IONS in Q3 2022 and has held it in 9 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Capital Advisors Ltd held 295 shares of Ionis Pharmaceuticals worth $23K as of Q2 2026.
Capital Advisors Ltd left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #659 holding.
Capital Advisors Ltd first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.